EBRIMA JATTA: Open Payments
NPI 1205134210 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $537 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| ABBVIE INC. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: COBENFY, CAPLYTA, VRAYLAR, UZEDY.
Industry payments across WA — which companies pay providers there.
